Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching from Valproic Acid to Depakote ER in Bipolar Patients
NCT00211250Phase 4Completed
- Sponsor
- Joliet Center for Clinical Research
- Start
- Jul 2005
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of divalproex sodium in bipolar I disorder and Bipolar II disorder (BP-II), sponsored by Joliet Center for Clinical Research. Primary endpoints: Safety and Tolerability, Adverse Events and 1 more. Started Jul 2005; status: completed.
02
Drugs
divalproex sodium
03
Conditions
bipolar I disorderBipolar II disorder (BP-II)
Beyond the preview
Go deeper on NCT00211250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00211250.